Retrospective population-based studies suggest that AMPK may act as a tumor suppressor because metformin, an inhibitor of mitochondrial electron transport complex 1 and an indirect AMPK activator, appears to decrease the risk for cancer22,23. The gene discussed is PRKAA1; the disease is neoplasm.